skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Early estrogen-induced metabolic changes and their inhibition by actinomycin D and cycloheximide in human breast cancer cells: sup 31 P and sup 13 C NMR studies

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America; (USA)
;  [1]
  1. Weizmann Institute of Science, Rehovot (Israel)

Metabolic changes following estrogen stimulation and the inhibition of these changes in the presence of actinomycin D and cycloheximide were monitored continuously in perfused human breast cancer T47D clone 11 cells with {sup 31}P and {sup 13}C NMR techniques. The experiments were performed by estrogen rescue of tamoxifen-treated cells. Immediately after perfusion with estrogen-containing medium, a continuous enhancement in the rates of glucose consumption, lactate production by glycolysis, and glutamate synthesis by the Krebs cycle occurred with a persistent 2-fold increase at 4 hr. Pretreatment with either actinomycin D or cycloheximide, at concentrations known to inhibit mRNA and protein synthesis, respectively, and simultaneous treatment with estrogen and each inhibitor prevented the estrogen-induced changes in glucose metabolism. This suggested that the observed estrogen stimulation required synthesis of mRNA and protein. These inhibitors also modulated several metabolic activities that were not related to estrogen stimulation. The observed changes in the in vivo kinetics of glucose metabolism may provide a means for the early detection of the response of human breast cancer cells to estrogen versus tamoxifen treatment.

OSTI ID:
5351854
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America; (USA), Vol. 86:14; ISSN 0027-8424
Country of Publication:
United States
Language:
English

Similar Records

CITED2 modulates estrogen receptor transcriptional activity in breast cancer cells
Journal Article · Fri Jul 26 00:00:00 EDT 2013 · Biochemical and Biophysical Research Communications · OSTI ID:5351854

Hispolon inhibits the growth of estrogen receptor positive human breast cancer cells through modulation of estrogen receptor alpha
Journal Article · Fri Aug 07 00:00:00 EDT 2015 · Biochemical and Biophysical Research Communications · OSTI ID:5351854

Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism
Journal Article · Mon Jul 15 00:00:00 EDT 2013 · Experimental Cell Research · OSTI ID:5351854